Serum Cytokines Profile In Celiac Disease And Healthy Subjects
DOI:
https://doi.org/10.46966/msjar.v4i3.148Keywords:
Celiac Disease, Anti-Tissue Transglutaminase IL-2, IFN-GammaAbstract
Background and aims: .In This study measuring the levels of some cytokines in Najaf patients with CD and to compare with healthy subjects. Methods : This case control study was done to check the levels of markers in the serum of( 60) patients the celiac disease(CD) and who randomly recruited from different Hospital in Najaf Iraq during period between September 2022and January 2023 This was done using the ELISA method, and the results were compared with those of 40 healthy people who were the same age (18-50) and sex. The ages of the people in the case group ranged from (18 to 50) of celiac disease. Results: the mean level of Interleukin -2(IL-2) high significant different between patients and healthy groups and IFN-gamma no significant, Anti-tissue transglutaminase levels correlated and were show statistically significant with these IL-2 cytokines .and negative correlation between the amounts of marker in the serum and sex. Conclusion:IL-2 play role of pathology of celiac disease.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Atika Ahmed Abd , Dr. Wasan Sami Hamad, Zinaalhilli
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
